(Q40235041)

18 September 2017

title

Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients (English)

1 reference

stem cell transplantation

18 September 2017

main subject

1 reference

1 reference

11

0 references

Martin S. Tallman

10

object named as

Martin Tallman

1 reference

18 September 2017

Steve Trifilio

1

1 reference

18 September 2017

Gennethel Pennick

2

1 reference

18 September 2017

Judy Pi

3

1 reference

18 September 2017

Jennifer Zook

4

1 reference

18 September 2017

Mary Golf

5

1 reference

18 September 2017

Kimberley Kaniecki

6

1 reference

18 September 2017

Seema Singhal

7

1 reference

18 September 2017

Stephanie Williams

8

1 reference

18 September 2017

Jane Winter

9

1 reference

18 September 2017

Olga Frankfurt

12

1 reference

18 September 2017

Andrew Evens

13

1 reference

18 September 2017

Jayesh Mehta

14

1 reference

18 September 2017

language of work or name

English

0 references

publication date

1 April 2007

1 reference

18 September 2017

1 reference

18 September 2017

volume

109

1 reference

18 September 2017

issue

8

1 reference

18 September 2017

page(s)

1532-1535

1 reference

Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22568

Evolving role of flucytosine in immunocompromised patients: new insights into safety, pharmacokinetics, and antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22568

Antifungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22568

7 January 2021

Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22568

7 January 2021

An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22568

7 January 2021

Practice guideline for the treatment of coccidioidomycosis. Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22568

7 January 2021

Voriconazole: a new triazole antifungal agent

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22568

7 January 2021

Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22568

7 January 2021

Adverse reactions to voriconazole.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22568

7 January 2021

Voriconazole therapeutic drug monitoring.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22568

7 January 2021

Development and validation of a high-performance liquid chromatography assay for voriconazole

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22568

7 January 2021

In vivo fluconazole pharmacodynamics and resistance development in a previously susceptible Candida albicans population examined by microbiologic and transcriptional profiling

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22568

7 January 2021

Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22568

7 January 2021

In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22568

7 January 2021

Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22568

7 January 2021

Identifiers

DOI

10.1002/CNCR.22568

1 reference

18 September 2017

1 reference